Volunteer for Clinical Studies

Related Links

Javascript Error

Your browser JavaScript is turned off causing certain features of the NIAID Institute of Allergy and Infectious Diseases web site to work incorrectly. Please visit your browser settings and turn JavaScript on.
Read more information on enabling JavaScript.

Diagnostics

Introduction

As infectious diseases continue to take their toll around the world, there is an urgent need for rapid, highly sensitive, and specific clinical diagnostics that are easy to use, cost-effective, and can diagnose individuals infected with pathogens or exposed to toxins.

Accurate diagnoses are essential for public health laboratories, hospital-based clinical laboratories, and point-of-care settings so that appropriate therapy can be initiated. Medical diagnostics that will rapidly identify infections are a high priority, as are diagnostic tools to determine drug sensitivities and detect a broad range of infectious agents in clinical specimens.

There are a variety of Parent Announcements applicants may use to submit their Investigator-initiated research projects including R01, R03, R21 activity codes, as well as funding opportunities available to Small Businesses (see below). Each Parent Announcement has three receipt dates per year.

In addition to investigator-initiated funding opportunities, NIAID periodically releases Request for Application (RFA) announcements to stimulate targeted research by requesting grant applications in a well-defined scientific area such as diagnostics development. Unlike the Parent Announcements, RFAs have a single receipt date and identify funds set aside and the number of awards likely to be made.

Current Diagnostics Funding Opportunities Available to Small Businesses